Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 866 entries
View as:

ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02517528 Org: User:
Start: 07/20/15 End: 03/16/17 Due: 03/16/18

An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT00619866 Org: User:
Start: 02/19/08 End: 08/28/09 Due: 08/28/10

Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care

Phase: N/A Priority: Normal
NCT ID: NCT04780516 Org: User:
Start: 04/26/21 End: 01/31/26 Due: 01/31/27

Study to Assess Accuracy of Rapid Mood Screener in Adult Participants With Unipolar Major Depressive Disorder or Bipolar 1 Disorder in Real World Setting

Phase: N/A Priority: Normal
NCT ID: NCT05956483 Org: User:
Start: 12/04/23 End: 08/16/24 Due: 08/16/25

Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06459297 Org: User:
Start: 06/24/24 End: 12/31/25 Due: 12/31/26

A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06068855 Org: User:
Start: 10/17/23 End: 11/30/25 Due: 11/30/26

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

Phase: N/A Priority: Normal
NCT ID: NCT06417775 Org: User:
Start: 09/10/24 End: 09/30/27 Due: 09/30/28

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05889182 Org: User:
Start: 06/21/23 End: 03/31/28 Due: 03/31/29

A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06257875 Org: User:
Start: 03/23/24 End: 04/30/28 Due: 04/30/29

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01960855 Org: User:
Start: 10/31/13 End: 07/31/15 Due: 07/31/16

A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

Phase: N/A Priority: Normal
NCT ID: NCT02814175 Org: User:
Start: 08/05/16 End: 03/19/20 Due: 03/19/21

An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT02925494 Org: User:
Start: 09/14/16 End: 03/22/19 Due: 03/22/20

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04777994 Org: User:
Start: 03/09/21 End: 10/31/26 Due: 10/31/27

A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT06063967 Org: User:
Start: 11/15/23 End: 02/28/29 Due: 02/28/30

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT03850782 Org: User:
Start: 02/28/19 End: 08/09/25 Due: 08/09/26

A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review

Phase: N/A Priority: Normal
NCT ID: NCT06503536 Org: User:
Start: 08/06/24 End: 10/31/24 Due: 10/31/25

A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02198651 Org: User:
Start: 01/05/15 End: 08/08/18 Due: 08/08/19

A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199

Phase: N/A Priority: Normal
NCT ID: NCT01969669 Org: User:
Start: 12/31/13 End: 09/30/14 Due: 09/30/15

A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax

Phase: N/A Priority: Normal
NCT ID: NCT01121133 Org: User:
Start: 05/31/10 End: 05/31/11 Due: 05/31/12

A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting

Phase: N/A Priority: Normal
NCT ID: NCT05139836 Org: User:
Start: 12/13/21 End: 11/30/26 Due: 11/30/27

A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina

Phase: N/A Priority: Normal
NCT ID: NCT04976777 Org: User:
Start: 10/12/21 End: 02/09/22 Due: 02/09/23

A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain

Phase: N/A Priority: Normal
NCT ID: NCT03343067 Org: User:
Start: 12/27/17 End: 10/23/18 Due: 10/23/19

Evaluation of Diet and Exercise in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01960881 Org: User:
Start: 09/19/13 End: 08/10/21 Due: 08/10/22

BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02694523 Org: User:
Start: 03/31/16 End: 08/31/17 Due: 08/31/18

Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04454658 Org: User:
Start: 11/11/20 End: 11/02/24 Due: 11/02/25